Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $257.93 Analyst target: $303.89 Upside: 17.82%
Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.
See the full interactive analysis & chart →Informational only — not investment advice.